Analyst Ratings for Liminal BioSciences, Inc. (LMNL)

LMNL Rating Summary

LMNL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LMNL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $16.50 (+269.1%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/18/2021 H.C. Wainwright Edwin Zhang New Coverage Buy
(N/A)
11.00
(N/A)
5.74
(4.47)
-22.13% Details
12/21/2020 Piper Sandler Yasmeen Rahimi New Coverage Overweight
(N/A)
22.00
(N/A)
4.09
(4.47)
9.29% Details
Like LMNL Ratings? Also take a look at ADMA, CERS, XBIT, IBIO

LMNL Ratings News